Topic: Denmark Model

1 chapters across the catalog

Del Bigtree discusses a significant proposed reduction in the U.S. childhood vaccine schedule, moving toward a model similar to Denmark's. The plan involves reducing the number of shots from 54 to approximately 23 and requiring rigorous double-blind placebo safety trials. Bigtree notes that Moderna CEO Stéphane Bancel recently cited this regulatory pressure as a reason for halting certain phase three vaccine trials.